RA CAPITAL MANAGEMENT, L.P. Q2 2023 Filing
Filed August 14, 2023
Portfolio Value
$5296.5T
Holdings
54
Report Date
Q2 2023
Filing Type
13F-HR
All Holdings (54 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ASNDASCENDIS PHARMA A/S | 11,225,357 | $1001.9T | 18.92% | |
| 2 | LEGNLEGEND BIOTECH CORP | 6,264,707 | $432.5T | 8.16% | |
| 3 | PCVXVAXCYTE INC | 7,891,254 | $394.1T | 7.44% | |
| 4 | —DICE THERAPEUTICS INC | 7,856,612 | $365.0T | 6.89% | |
| 5 | ETNBGBP89BIO INC | 11,416,948 | $216.4T | 4.08% | |
| 6 | BIIBBIOGEN INC | 532,892 | $151.8T | 2.87% | |
| 7 | AVTEAEROVATE THERAPEUTICS INC | 8,263,982 | $141.7T | 2.68% | |
| 8 | VRNAVERONA PHARMA PLC | 6,317,990 | $133.6T | 2.52% | |
| 9 | CVACCUREVAC N V | 12,245,955 | $127.6T | 2.41% | |
| 10 | TYRATYRA BIOSCIENCES INC | 7,236,454 | $123.2T | 2.33% | |
| 11 | NAMSNEWAMSTERDAM PHARMA COMPANY | 9,000,000 | $107.0T | 2.02% | |
| 12 | CTKBCYTEK BIOSCIENCES INC | 12,297,721 | $105.0T | 1.98% | |
| 13 | JANXJANUX THERAPEUTICS INC | 8,670,644 | $102.9T | 1.94% | |
| 14 | GONGERON CORP | 31,544,806 | $101.3T | 1.91% | |
| 15 | INBXUSDINHIBRX INC | 3,853,867 | $100.0T | 1.89% | |
| 16 | RYTMRHYTHM PHARMACEUTICALS INC | 5,676,067 | $93.6T | 1.77% | |
| 17 | DAWNDAY ONE BIOPHARMACEUTICALS I | 7,809,852 | $93.2T | 1.76% | |
| 18 | RXSTRXSIGHT INC | 3,052,796 | $87.9T | 1.66% | |
| 19 | COGTCOGENT COMMUNICATIONS HLDGS | 6,416,147 | $76.0T | 1.43% | |
| 20 | PEPGPEPGEN INC | 8,131,952 | $72.7T | 1.37% | |
| 21 | AXSMAXSOME THERAPEUTICS INC | 1,000,000 | $71.9T | 1.36% | |
| 22 | RNAAVIDITY BIOSCIENCES INC | 6,416,998 | $71.2T | 1.34% | |
| 23 | VORVOR BIOPHARMA INC | 22,748,880 | $70.3T | 1.33% | |
| 24 | GHRSGH RESEARCH PLC | 5,587,333 | $66.3T | 1.25% | |
| 25 | WVEWAVE LIFE SCIENCES LTD | 17,202,009 | $62.6T | 1.18% | |
| 26 | ACRVACRIVON THERAPEUTICS INC | 4,810,508 | $62.3T | 1.18% | |
| 27 | —ICOSAVAX INC | 5,963,565 | $59.2T | 1.12% | |
| 28 | 5E7ITEOS THERAPEUTICS INC | 4,417,259 | $58.5T | 1.10% | |
| 29 | FDMT4D MOLECULAR THERAPEUTICS IN | 3,069,531 | $55.5T | 1.05% | |
| 30 | MLYSMINERALYS THERAPEUTICS INC | 3,178,476 | $54.2T | 1.02% | |
| 31 | NVLSEURALPINE IMMUNE SCIENCES INC | 4,691,178 | $48.2T | 0.91% | |
| 32 | VRDNVIRIDIAN THERAPEUTICS INC | 2,007,946 | $47.8T | 0.90% | |
| 33 | ABOSACUMEN PHARMACEUTICALS INC | 9,770,773 | $47.0T | 0.89% | |
| 34 | ACRSACLARIS THERAPEUTICS INC | 4,398,453 | $45.6T | 0.86% | |
| 35 | IMGNEURIMMUNOGEN INC | 2,329,958 | $44.0T | 0.83% | |
| 36 | ELVNENLIVEN THERAPEUTICS INC | 2,122,465 | $43.3T | 0.82% | |
| 37 | FULCFULCRUM THERAPEUTICS INC | 11,609,704 | $38.3T | 0.72% | |
| 38 | CLYMELIEM THERAPEUTICS INC | 13,150,849 | $36.8T | 0.70% | |
| 39 | TNYATENAYA THERAPEUTICS INC | 6,067,483 | $35.6T | 0.67% | |
| 40 | ANTXAN2 THERAPEUTICS INC | 3,773,517 | $32.1T | 0.61% | |
| 41 | PLRXPLIANT THERAPEUTICS INC | 1,762,000 | $31.9T | 0.60% | |
| 42 | EYPTEYEPOINT PHARMACEUTICALS INC | 3,370,506 | $29.3T | 0.55% | |
| 43 | SPRYARS PHARMACEUTICALS INC | 3,009,678 | $20.2T | 0.38% | |
| 44 | HOWLWEREWOLF THERAPEUTICS INC | 6,144,881 | $18.7T | 0.35% | |
| 45 | DSGNDESIGN THERAPEUTICS INC | 2,971,231 | $18.7T | 0.35% | |
| 46 | SLDBSOLID BIOSCIENCES INC | 3,426,286 | $18.0T | 0.34% | |
| 47 | BDTXBLACK DIAMOND THERAPEUTICS I | 3,525,754 | $17.8T | 0.34% | |
| 48 | NKTXNKARTA INC | 7,805,129 | $17.1T | 0.32% | |
| 49 | CELCCELCUITY INC | 1,400,001 | $15.4T | 0.29% | |
| 50 | 1K0IGM BIOSCIENCES INC | 937,500 | $8.7T | 0.16% | |
| 51 | CNTBCONNECT BIOPHARMA HLDGS LTD | 6,991,003 | $7.9T | 0.15% | |
| 52 | —TALARIS THERAPEUTICS INC | 2,333,175 | $7.1T | 0.13% | |
| 53 | NSTGEURNANOSTRING TECHNOLOGIES | 1,723,373 | $7.0T | 0.13% | |
| 54 | NAMSNEWAMSTERDAM PHARMA COMPANY | 333,333 | $696.7B | 0.01% |